182 related articles for article (PubMed ID: 5306221)
1. Differences in the oxidative metabolism of drugs by liver microsomes.
Kato R; Takayanagi M; Oshima T
Jpn J Pharmacol; 1969 Mar; 19(1):53-62. PubMed ID: 5306221
[No Abstract] [Full Text] [Related]
2. The diphasic action of halothane on the oxidative metabolism of drugs by the liver. An in-vitro study in the rat.
Brown BR
Anesthesiology; 1971 Sep; 35(3):241-6. PubMed ID: 5095536
[No Abstract] [Full Text] [Related]
3. Possible role of P-450 in the oxidation of drugs in liver microsomes.
Kato R
J Biochem; 1966 Jun; 59(6):574-83. PubMed ID: 4381416
[No Abstract] [Full Text] [Related]
4. Sex differences in the effects of abnormal physiological states on the metabolism of drugs by rat liver microsomes.
Kato R; Gillette JR
J Pharmacol Exp Ther; 1965 Nov; 150(2):285-91. PubMed ID: 4285416
[No Abstract] [Full Text] [Related]
5. Species difference in the inhibition of drug metabolism by liver microsomes by different inhibitors.
Kato R; Onoda K; Takayanagi M
Jpn J Pharmacol; 1969 Sep; 19(3):438-50. PubMed ID: 4390624
[No Abstract] [Full Text] [Related]
6. Further studies on the metabolism of drugs by subfractions of hepatic microsomes.
Gram TE; Rogers LA; Fouts JR
J Pharmacol Exp Ther; 1967 Mar; 155(3):479-93. PubMed ID: 6022622
[No Abstract] [Full Text] [Related]
7. Drug metabolism by hepatic microsomes from phenobarbital-treated or starved male and female rats in the presence of inhibitors.
Gigon PL; Bickel MH
Life Sci II; 1971 Feb; 10(3):163-73. PubMed ID: 4252538
[No Abstract] [Full Text] [Related]
8. Time course differences in the metabolism of drugs by hepatic microsomes from rats, rabbits and mice.
Gram TE; Fouts JR
J Pharmacol Exp Ther; 1966 Jun; 152(3):363-71. PubMed ID: 5922307
[No Abstract] [Full Text] [Related]
9. Toxicity and metabolism of drugs in relation to dietary protein.
Kato R; Oshima T; Tomizawa S
Jpn J Pharmacol; 1968 Sep; 18(3):356-66. PubMed ID: 4387788
[No Abstract] [Full Text] [Related]
10. Effect of dibromotetrafluoroethane inhalation on hepatic drug metabolism in mice.
Murphy JP; Van Stee EW; Back KC
Biochem Pharmacol; 1973 Nov; 22(22):2843-51. PubMed ID: 4761555
[No Abstract] [Full Text] [Related]
11. Sex-related differences in drug metabolism.
Kato R
Drug Metab Rev; 1974; 3(1):1-32. PubMed ID: 4154185
[No Abstract] [Full Text] [Related]
12. Studies on the mechanism of sex difference in drug-oxidizing activity of liver microsomes.
Kato R; Takanaka A; Takayanagi M
Jpn J Pharmacol; 1968 Dec; 18(4):482-9. PubMed ID: 4388258
[No Abstract] [Full Text] [Related]
13. Influence of clofibrate (ethyl-4-chlorophenoxyisobutyrate) on hepatic drug metabolism in male rats.
Lewis NJ; Witiak DT; Feller DR
Proc Soc Exp Biol Med; 1974 Jan; 145(1):281-5. PubMed ID: 4812862
[No Abstract] [Full Text] [Related]
14. Hepatic drug metabolism after phenobarbital or 3-methylcholanthrene pretreatment of rats bearing a pituitary tumor.
Wilson JT
Proc Soc Exp Biol Med; 1968 Jun; 128(2):445-8. PubMed ID: 5663252
[No Abstract] [Full Text] [Related]
15. Effects of morphine treatment and starvation on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes.
Kato R; Onoda K; Sasajima M
Jpn J Pharmacol; 1970 Jun; 20(2):194-209. PubMed ID: 4393947
[No Abstract] [Full Text] [Related]
16. Effect of phenobarbital and methylcholanthrene treatment on drug-induced difference spectrum of liver microsomes.
Kato R; Takanaka A
Jpn J Pharmacol; 1969 Mar; 19(1):171-3. PubMed ID: 5306217
[No Abstract] [Full Text] [Related]
17. The effect of a pituitary mammotropic tumor on hepatic microsomal drug metabolism in the rat.
Wilson JT
Biochem Pharmacol; 1968 Jul; 17(7):1449-57. PubMed ID: 5690694
[No Abstract] [Full Text] [Related]
18. Thyroid hormone and activities of drug-metabolizing enzymes and electron transport systems of rat liver microsomes.
Kato R; Takahashi A
Mol Pharmacol; 1968 Mar; 4(2):109-20. PubMed ID: 5645609
[No Abstract] [Full Text] [Related]
19. Studies on age difference in mice for the activity of drug-metabolizing enzymes of liver microsomes.
Kato R; Takanaka A; Onoda K
Jpn J Pharmacol; 1970 Dec; 20(4):572-6. PubMed ID: 5312939
[No Abstract] [Full Text] [Related]
20. Effect of adrenalectomy or alloxan diabetes on the substrate interaction with cytochrome P-450 in the oxidation of drugs by liver microsomes.
Kato R; Takanaka A; Onoda K
Biochem Pharmacol; 1971 Feb; 20(2):447-58. PubMed ID: 5150143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
